References
- Becker M.T., Shores C.G., Yu K.K., Yarbrough W.G. Molecular assay to detect metastatic head and neck squamous cell carcinoma. Arch Otolaryngol. Head Neck Surg. 2004; 130: 21–27
- Ferlito A., Shaha A.R., Rinaldo A. The incidence of lymph node micrometastases in patients with pathologically staged N0 in cancer of oral cavity and oropharynx. Oral Oncol. 2002; 38: 3–5
- Nemeth Z., Velich N., Bogdan S., et al. The prognostic role of clinical, morphological and molecular markers in oral squamous cell tumors. Neoplasma 2005; 52(2)95–102
- Resing K.A., Ahn N.G. Proteomics strategies for protein identification. FEBS Lett. 2005; 579(4)885–889
- Merchant M., Weinberger S.R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000; 21(6)1164–1177
- Xu, Wen-hong, Chen, Yi-ding, Hu, Yue, Yu, Jie-kai, , et al. 2006. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients. J Zhejiang Univ. Science B, 7(3)235–240.
- Issaq H.J., Veenstra T.D., Conrads T.P., Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 2002; 292(3)587–592
- Weinberger S.R., Morris T.S., Pawlak M. Recent trends in protein biochip technology. Pharmacogenomics 2000; 1(4)395–416